Topic · page 28 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,081–1,120 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

Diabetes Care19 Nov 2025
Metabolic Improvement Mediates the Causal Relationship Between GLP-1 Receptor Agonists and Myocardial Infarction: A Mendelian Randomization and Mediation Analysis Study
Research article
Cardiovasc Diabetol19 Nov 2025
Plasma metabolomics disentangles T2DM- and CAD-specific dysmetabolism and identifies potential biomarkers for CAD risk escalation in diabetic patients
Cross-sectional study
Cardiovasc Diabetol19 Nov 2025
Risk of all–cause death and pancreatic events following GLP-1 RA initiation in people with obesity or type 2 diabetes: observations from a federated research network
Cohort study
Diabetes Obes Metab19 Nov 2025
Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials
Meta-analysis
Diabetes Res Clin Pract19 Nov 2025
Gender and socioeconomic inequalities in the cascade of type 2 diabetes care trends among middle-aged and older Chinese
Cross-sectional study
Diabetes Obes Metab19 Nov 2025
Long‐term glycemic exposure, glycemic control stability and incident calcific aortic valve disease: A prospective cohort study
Cohort study
Lancet Diabetes Endocrinol19 Nov 2025
Trajectories of type 2 diabetes and cancer in 330 000 individuals with prediabetes: 20-year observational study in England
Cohort study
Int J Obes (Lond)18 Nov 2025
The prevalence of prediabetes is high and has rapidly increased, independent of the degree of obesity, in Finnish children with overweight or obesity
Cross-sectional study
Diabetes Care18 Nov 2025
Young-Onset Hypertension Confers Higher Risk of Cardiovascular Disease, Kidney Disease, and All-Cause Mortality in Individuals With Type 2 Diabetes: A Propensity Score–Matched Cohort Analysis
Cohort study
Cardiovasc Diabetol18 Nov 2025
Impact of left ventricular dilatation on biventricular function and deformation in diabetes mellitus with reduced ejection fraction: a CMR feature tracking study
Cross-sectional study
Diabetes Obes Metab18 Nov 2025
The value and impact of weight reduction from the perspective of people with type 2 diabetes in the United States
Cross-sectional study
Diabetes Obes Metab17 Nov 2025
Real‐world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network
Cohort study
Diabetes Obes Metab17 Nov 2025
Nomogram‐based prediction of hypoglycemia risk in elderly community‐dwelling patients with type 2 diabetes: Development and validation in a multicentre real‐world cohort
Diagnostic or prognostic study
Diabetologia17 Nov 2025
Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap
Guideline or statement
Diabetes Res Clin Pract17 Nov 2025
Global spatiotemporal Dynamics of Type 2 Diabetes Mellitus (T2DM) burden and projections: focusing on the impact of non-optimal temperature on adults aged 55+
Cohort study
Pediatr Obes17 Nov 2025
MRI Analysis of Cardiac Fat, Abdominal Adiposity and Cardiac Function After Vertical Sleeve Gastrectomy in Youth With Type 2 Diabetes
Cohort study
BMJ Open Diabetes Res Care16 Nov 2025
Text messaging interventions are associated with reductions in HbA1c among patients with diabetes: a systematic review and meta-analysis
Meta-analysis
Diabetes Res Clin Pract15 Nov 2025
Global guideline recommended target achievements in glycaemic, blood pressure, and lipid control in type 2 diabetes: An updated meta-analysis of 1,618,972 participants
Meta-analysis
J Clin Endocrinol Metab15 Nov 2025
Metabolism and Type 2 Diabetes Across Life Stages in Klinefelter Syndrome: A Population-Based Cohort Study
Cohort study
Diabetes Care14 Nov 2025
Novel Phenotypic Clusters of Youth-Onset Type 2 Diabetes Offer No Added Prognostic Value to Simple Clinical Measures
Secondary analysis
Diabetes Obes Metab14 Nov 2025
Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial
Randomized controlled trial
Cardiovasc Diabetol14 Nov 2025
Favorable outcomes of SGLT2 inhibitor use in pacemaker recipients: a population-based study
Cohort study
Pediatr Obes14 Nov 2025
Risk Factors for Development of Type 2 and Prediabetes in Children During the COVID ‐19 Pandemic
Cohort study
Diabetes Obes Metab14 Nov 2025
Prescribing of glucose‐lowering medication to adults with type 2 diabetes by severe mental illness status in Scotland: A cohort study
Cohort study
Lancet Diabetes Endocrinol14 Nov 2025
Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Sweden
Cohort study
Diabetes Res Clin Pract14 Nov 2025
Disparities of adiposity explained ethnic differences in insulin sensitivity and secretion traits in adolescents with normoglycaemia
Cross-sectional study
Diabetes Care13 Nov 2025
Sodium–Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes
Cohort study
Diabetes Care13 Nov 2025
GLP-1s Versus DPP-4s and Risk of Dementia in Patients Requiring Hemodialysis: A Target Trial Emulation Study
Research article
Endocr Pract13 Nov 2025
Real-World Evidence for Metformin Use in Solid Organ Transplant Recipients Living With Diabetes
Cohort study
Diabetes Obes Metab12 Nov 2025
Ethnic differences in the comparative effectiveness of second‐line type 2 diabetes medications in preventing cardiovascular disease
Cohort study
Diabetes Obes Metab12 Nov 2025
Estimating the risk of cardiovascular outcomes and all‐cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data
Diagnostic or prognostic study
Diabetes Obes Metab12 Nov 2025
Initiation of sodium‐glucose cotransporter‐2 inhibitors and the risk of infection‐related hospitalisations: A population‐based cohort study
Cohort study
Diabet Med12 Nov 2025
VEGFA ‐centric angiogenic genetic variants drive hypertension and dyslipidaemia susceptibility in type 2 diabetes mellitus: A multilocus synergistic cohort study
Cohort study
Cardiovasc Diabetol11 Nov 2025
A six-year longitudinal study identifies a statin-independent association between low LDL-cholesterol and risk of type 2 diabetes
Cohort study
Diabetes Obes Metab11 Nov 2025
Baseline characteristics in the SYNCHRONIZE ™‐2 randomized phase 3 trial of survodutide, a glucagon receptor/ GLP ‐1 receptor dual agonist, for obesity in people with type 2 diabetes
Randomized controlled trial
Cardiovasc Diabetol11 Nov 2025
Artificial intelligence identifies individuals with prediabetes using single-lead electrocardiograms
Diagnostic or prognostic study
Cardiovasc Diabetol10 Nov 2025
Electronic nose for detecting abnormal glucose metabolism in heart transplant recipients
Diagnostic or prognostic study
Diabetes Obes Metab10 Nov 2025
Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
Randomized controlled trial
Diabetes Obes Metab10 Nov 2025
The global burden of early‐onset type 2 diabetes (1990–2050): An age–period–cohort analysis of incidence, disparities, and projections
Secondary analysis
Diabetes Obes Metab10 Nov 2025
Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study
Cohort study

All 4,758 Briefs in ExploreShowing Briefs 1,081–1,120 of 4,758, newest first